Prospera Financial Services’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-48,780
| Closed | -$200K | – | 1204 |
|
|
2024
Q2 | $200K | Buy |
48,780
+24,745
| +103% | +$101K | 0.01% | 1073 |
|
|
2024
Q1 | $379K | Buy |
24,035
+5,733
| +31% | +$90.4K | 0.01% | 807 |
|
|
2023
Q4 | $277K | Buy |
+18,302
| New | +$277K | 0.01% | 880 |
|
|
2022
Q3 | – | Sell |
-89
| Closed | -$2K | – | 1615 |
|
|
2022
Q2 | $2K | Sell |
89
-2,161
| -96% | -$48.6K | ﹤0.01% | 1578 |
|
|
2022
Q1 | $104K | Buy |
+2,250
| New | +$104K | ﹤0.01% | 1101 |
|